SCHEMBL9249902

SCHEMBL9249902

CC(C)c1cccc2n(C(C)c3ccc(O)c(O)c3)c(=O)c(-c3nnn[nH]3)c-2c1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.33
MDM4 O15151 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
TP53 P04637 1/20 0.33
CYP3A4 P08684 1/20 0.33
MAPT P10636 1/20 0.33
TYR P14679 1/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
ALOX12 P18054 1/20 0.33
CA5A P35218 1/20 0.33
HTT P42858 1/20 0.33
HDAC4 P56524 1/20 0.33
MDM2 Q00987 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CA9 Q16790 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9250230 0.89
SCHEMBL9249911 0.80 CASR (0.35) KDM4EMDM4ALDH1A1CA1CA2
SCHEMBL9160543 0.74 MIF (0.37) KDM4EALDH1A1MAPTHPGDALOX12
SCHEMBL9251207 0.74 P2RX3 (0.37) KDM4EMAPTPTGS1
SCHEMBL9158524 0.72 L3MBTL1 (0.34) ALDH1A1TDP1
SCHEMBL9251582 0.71 ADORA3 (0.37) ALDH1A1TP53MDM2SMN1; SMN2
SCHEMBL9253222 0.71 GRIN1 (0.38) KDM4EALDH1A1CYP3A4
SCHEMBL9159745 0.69 HDAC4 (0.37) KDM4EMDM4ALDH1A1CA1CA2
SCHEMBL9156137 0.68 KMT2A (0.37) KDM4EALDH1A1MAPTSMN1; SMN2TDP1
SCHEMBL9243990 0.68 GNRHR (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE34918-E Antihistamines, muscle relaxants KAKEN PHARMACEUTICAL CO., LTD. (JP) 1995-04-25 US disclosed
US-5013736-A 5-lipoxygenase inhibitors, smooth muscle relaxants KAKEN PHARMACEUTICAL CO., LTD. (JP) 1991-05-07 US disclosed
EP-0376223-A2 Azaazulene derivative, process for preparing the same, and antiallergic agent and antiinflammatory agent containing the same Kaken Pharmaceutical Co., Ltd. (JP) 1990-07-04 EP disclosed